Beyond the Finish Line: Raising Millions for Prostate Cancer Research and Advocacy

Whether your prostate cancer benefit run has 250 or 3,000 people show up in support, you’re doing valuable work to serve your community.

Today’s guest partners with ZERO, The End of Prostate Cancer, because he wants to help even more than just the individual patients he sees.

In this episode, we interview Dr. Benjamin Lowentritt, Partner at Chesapeake Urology Associates, about how a run for prostate cancer turned into several millions to support research and patient advocacy.

What we talked about:

• How the run & partnership with ZERO came about
• People who underestimate prostate cancer
• Belonging to a community of supporters, advocates, & cheerleaders
• ZEROcancer.org

Stay connected with Working in Oncology on Apple Podcasts, Spotify, or our podcast website.

Here are the show highlights

• Dr. Lowentritt’s mission to treat more than just his own patients (7:36)
• The ZERO run is the Komen for prostate cancer (9:37)
• Cheerleaders, COVID-19, and the power of advocacy (15:32)
• The controversy about prostate cancer & why not to underestimate it (19:51)
• Advice for practices who are ready to become advocates (22:38)

Guest Bio

Dr. Benjamin Lowentritt is a partner at Chesapeake Urology Associates and a graduate of Baylor College of Medicine. He has a particular focus on robotic urology procedures and was the first surgeon in Maryland to perform robot- assisted surgery for bladder cancer.